# George Somlo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/george-somlo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,861 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 77 |
| i10-index | 234 |
| Last Known Institution | City of Hope |
| OpenAlex ID | https://openalex.org/A5023917993 |
| Works | 544 |

## Researcher papers

- [Association of reactive oxygen species levels and radioresistance in cancer stem cells](https://scholariq.org/papers/association-of-reactive-oxygen-species-levels-and-radioresistance-in-cancer-stem/)
- [2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline](https://scholariq.org/papers/2006-update-of-recommendations-for-the-use-of-white-blood-cell-growth-factors-an/)
- [Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells](https://scholariq.org/papers/downregulation-of-mirna-200c-links-breast-cancer-stem-cells-with-normal-stem/)
- [Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis](https://scholariq.org/papers/breast-cancer-secreted-mir-122-reprograms-glucose-metabolism-in-premetastatic/)
- [2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines](https://scholariq.org/papers/2000-update-of-recommendations-for-the-use-of-hematopoietic-colony-stimulating/)
- [Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)](https://scholariq.org/papers/impact-of-the-addition-of-carboplatin-and-or-bevacizumab-to-neoadjuvant-once-per/)
- [Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update](https://scholariq.org/papers/recommendations-for-the-use-of-wbc-growth-factors-american-society-of-clinical/)
- [STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth](https://scholariq.org/papers/stat3-activation-induced-fatty-acid-oxidation-in-cd8-t-effector-cells-is/)
- [Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial](https://scholariq.org/papers/autologous-transplantation-consolidation-and-maintenance-therapy-in-multiple/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [City of Hope](https://scholariq.org/institutions/city-of-hope/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.